2025 Invited and Confirmed Panelists
- Stanley Abel, MBA, CEO, ProJenX
- Peter Alff, PhD, Venture Partner, Orange Grove Bio
- Selin Altinok, PhD, Investment Analyst, IndieBio NY
- Marc Appel, JD, MBA, Managing Partner, Pacific Bridge NY
- Artavazd Arumov, PhD, Principal, Qiming Venture Partners USA
- Michael Baran, PhD, MBA, Partner, Pfizer Ventures, Executive Director, External Science & Innovation, Worldwide R&D, Pfizer, Inc.
- Michael R. Bielski, JD, MS, Founder & President, DevTech Partners
- Megan Blewett, PhD, Principal, Scion Life Sciences
- Laurence Blumberg, MD, Biotechnology Executive
- Scott P. Bruder, MD, PhD, Founder & CEO, Bruder Consulting & Venture Group
- Kara Cannon, CEO & Board Member, Enzo Biochem Inc.
- Bruce Cohen, Venture Partner, Xeraya Life Capital; Chairman and CEO, Buckle Therapeutics, Inc.
- Keith Comito, CEO & President, Lifespan Research Institute
- Ting Feng, PhD, Partner, Sirona Capital
- Anjali Ganguli, PhD, Chief Strategy Officer at Syndax Pharmaceuticals
- Sherry Grisewood, CFA, Senior Investment Officer, FoxHill Asset Management
- Jiaping Gu, PhD, Investment Director & Partner, Takeda Ventures
- Tamar R. Gubins, Partner, Fox Rothschild LLP
- Sonia Gulati, PhD, Partner, Global BioAccess Fund
- Matt Kaeberlein, PhD, CEO Optispan, Advisor, Circulate Health
- Kim Kamdar, PhD, Managing Partner, Medical Excellence Capital, LLC
- Parastoo Khoshakhlagh, PhD, CEO and Co-Founder, GC Therapeutics
- Seema Kumar, MS, CEO, CURE
- Sanford J. Madigan, PhD, Managing Partner, Avalon BioVentures
- Jonathan Mandelbaum, PhD, Vice President, OrbiMed
- Aamir Mecklai, MBA, Managing Director, Healthcare Investment Banking, Bank of America
- Fiona Miller, Managing Partner, quadraScope
- John Prufeta, General Partner, Medical Excellence Capital, LLC
- Kim Raineri, MBA, Chief Technology Officer, Aspen Neuroscience
- Reason, MS, CEO, Repair Biotechnologies
- Clinton T. Rubin, PhD, Director, Center for Biotechnology
- Nina Tandon, PhD, MBA, CEO & Co-Founder, EpiBione, Inc.
- James Tonra, PhD, President & CSO, Seed Therapeutics
- Michael Torres, PhD, CrossBridge Bio CEO & Co-Founder
- Arda Ural, PhD, Americas Life Sciences Leader, Ernst & Young LLP
- Elliot Warner, PhD, Associate, Scion Life Sciences
- Julie Wolf, PhD, Partner, 2048 Ventures
- Cookie Yu, PhD, Investment Director, Samsung Ventures
- Su Zhang, PharmD, MBA, CEO & acting CBO, CoDevCo
- Alex Zisson, Managing Director, H.I.G. Capital